The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Breast Cancer Treatment Devices Market Research Report 2024
Synopsis
Breast cancer treatment devices are medical devices used in the diagnosis, treatment, and management of breast cancer. These devices play a crucial role in detecting, staging, and treating breast cancer, as well as monitoring treatment response.
Global Breast Cancer Treatment Devices market is projected to reach US$ 52210 million in 2029, increasing from US$ 29500 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Breast Cancer Treatment Devices market research.
The market for breast cancer treatment devices is driven by several factors, including the increasing prevalence of breast cancer worldwide, advancements in medical technology, rise in awareness about early detection, and an aging population. Additionally, government initiatives and awareness campaigns promoting breast cancer screening have also boosted market growth.
Here are some key segments and factors driving the global breast cancer treatment devices market:
Diagnostic Devices: This segment includes mammography machines, breast ultrasound systems, breast MRI machines, and breast biopsy devices. The increasing emphasis on early detection and accurate diagnosis of breast cancer has propelled the demand for these devices.
Surgical Devices: Surgical tools and devices used in breast cancer surgeries, such as lumpectomy or mastectomy procedures, fall under this segment. The demand for precise and minimally invasive surgical techniques has driven the market for these devices.
Radiation Therapy Devices: Radiation therapy machines, including linear accelerators, targeted radiation systems, and brachytherapy devices, are used in the treatment of breast cancer. These devices deliver radiation to destroy cancer cells and reduce the risk of recurrence. The growing adoption of radiation therapy as an effective treatment option has contributed to the market growth.
Chemotherapy Devices: Devices used in the delivery of chemotherapy drugs for breast cancer treatment, such as infusion pumps and implantable ports, are part of this segment. The increasing prevalence of chemotherapy as a systemic treatment for breast cancer has driven the demand for these devices.
Other Supportive Devices: This segment includes lymphedema management devices, prosthetics, and breast reconstruction devices, which aim to improve the quality of life for breast cancer survivors. These devices help manage post-treatment side effects and provide aesthetic solutions.
Geographically, North America and Europe dominate the global breast cancer treatment devices market due to well-established healthcare infrastructure and higher awareness levels. However, emerging economies in the Asia-Pacific region and Latin America are witnessing significant growth due to improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about breast cancer.
Key players in the global breast cancer treatment devices market include medical device manufacturers, imaging equipment manufacturers, and providers of surgical tools and devices. These companies focus on research and development activities to introduce innovative and technologically advanced devices to the market.
Overall, with the increasing global burden of breast cancer and advancements in medical technology, the global breast cancer treatment devices market is expected to witness substantial growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Breast Cancer Treatment Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Advanced Radiation Therapy
Agilent Technologies
Becton
Xcision Medical Systems, LLC
BioGenex Laboratories
Danaher Corporation
Fujifilm Holdings Corporation
GE Healthcare
General Medical Merate SpA
Hologic
iCAD Inc.
IceCure Medical Ltd
IntraOp Medical Corporation
Myriad Genetics
Parascript, LLC
Philips Healthcare
Planmed Oy
Qiagen NV
Roche Holding AG
Sanarus Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific
Segment by Type
Diagnostic Imaging Devices
Surgical Procedure Devices
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
Segment by Application
Hospital
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Breast Cancer Treatment Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Breast cancer treatment devices are medical devices used in the diagnosis, treatment, and management of breast cancer. These devices play a crucial role in detecting, staging, and treating breast cancer, as well as monitoring treatment response.
Global Breast Cancer Treatment Devices market is projected to reach US$ 52210 million in 2029, increasing from US$ 29500 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Breast Cancer Treatment Devices market research.
The market for breast cancer treatment devices is driven by several factors, including the increasing prevalence of breast cancer worldwide, advancements in medical technology, rise in awareness about early detection, and an aging population. Additionally, government initiatives and awareness campaigns promoting breast cancer screening have also boosted market growth.
Here are some key segments and factors driving the global breast cancer treatment devices market:
Diagnostic Devices: This segment includes mammography machines, breast ultrasound systems, breast MRI machines, and breast biopsy devices. The increasing emphasis on early detection and accurate diagnosis of breast cancer has propelled the demand for these devices.
Surgical Devices: Surgical tools and devices used in breast cancer surgeries, such as lumpectomy or mastectomy procedures, fall under this segment. The demand for precise and minimally invasive surgical techniques has driven the market for these devices.
Radiation Therapy Devices: Radiation therapy machines, including linear accelerators, targeted radiation systems, and brachytherapy devices, are used in the treatment of breast cancer. These devices deliver radiation to destroy cancer cells and reduce the risk of recurrence. The growing adoption of radiation therapy as an effective treatment option has contributed to the market growth.
Chemotherapy Devices: Devices used in the delivery of chemotherapy drugs for breast cancer treatment, such as infusion pumps and implantable ports, are part of this segment. The increasing prevalence of chemotherapy as a systemic treatment for breast cancer has driven the demand for these devices.
Other Supportive Devices: This segment includes lymphedema management devices, prosthetics, and breast reconstruction devices, which aim to improve the quality of life for breast cancer survivors. These devices help manage post-treatment side effects and provide aesthetic solutions.
Geographically, North America and Europe dominate the global breast cancer treatment devices market due to well-established healthcare infrastructure and higher awareness levels. However, emerging economies in the Asia-Pacific region and Latin America are witnessing significant growth due to improving healthcare infrastructure, rising healthcare expenditure, and growing awareness about breast cancer.
Key players in the global breast cancer treatment devices market include medical device manufacturers, imaging equipment manufacturers, and providers of surgical tools and devices. These companies focus on research and development activities to introduce innovative and technologically advanced devices to the market.
Overall, with the increasing global burden of breast cancer and advancements in medical technology, the global breast cancer treatment devices market is expected to witness substantial growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Breast Cancer Treatment Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Advanced Radiation Therapy
Agilent Technologies
Becton
Xcision Medical Systems, LLC
BioGenex Laboratories
Danaher Corporation
Fujifilm Holdings Corporation
GE Healthcare
General Medical Merate SpA
Hologic
iCAD Inc.
IceCure Medical Ltd
IntraOp Medical Corporation
Myriad Genetics
Parascript, LLC
Philips Healthcare
Planmed Oy
Qiagen NV
Roche Holding AG
Sanarus Technologies Inc.
Siemens Healthineers AG
Thermo Fisher Scientific
Segment by Type
Diagnostic Imaging Devices
Surgical Procedure Devices
Directional Energy Therapy Equipment
Drug/Fluid Delivery and Infusion Therapy Devices
Others
Segment by Application
Hospital
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Breast Cancer Treatment Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Treatment Devices Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Diagnostic Imaging Devices
1.2.3 Surgical Procedure Devices
1.2.4 Directional Energy Therapy Equipment
1.2.5 Drug/Fluid Delivery and Infusion Therapy Devices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Breast Cancer Treatment Devices Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Outpatient Surgery Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Treatment Devices Market Perspective (2018-2029)
2.2 Breast Cancer Treatment Devices Growth Trends by Region
2.2.1 Global Breast Cancer Treatment Devices Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Breast Cancer Treatment Devices Historic Market Size by Region (2018-2023)
2.2.3 Breast Cancer Treatment Devices Forecasted Market Size by Region (2024-2029)
2.3 Breast Cancer Treatment Devices Market Dynamics
2.3.1 Breast Cancer Treatment Devices Industry Trends
2.3.2 Breast Cancer Treatment Devices Market Drivers
2.3.3 Breast Cancer Treatment Devices Market Challenges
2.3.4 Breast Cancer Treatment Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Treatment Devices Players by Revenue
3.1.1 Global Top Breast Cancer Treatment Devices Players by Revenue (2018-2023)
3.1.2 Global Breast Cancer Treatment Devices Revenue Market Share by Players (2018-2023)
3.2 Global Breast Cancer Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Treatment Devices Revenue
3.4 Global Breast Cancer Treatment Devices Market Concentration Ratio
3.4.1 Global Breast Cancer Treatment Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Treatment Devices Revenue in 2022
3.5 Breast Cancer Treatment Devices Key Players Head office and Area Served
3.6 Key Players Breast Cancer Treatment Devices Product Solution and Service
3.7 Date of Enter into Breast Cancer Treatment Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Treatment Devices Breakdown Data by Type
4.1 Global Breast Cancer Treatment Devices Historic Market Size by Type (2018-2023)
4.2 Global Breast Cancer Treatment Devices Forecasted Market Size by Type (2024-2029)
5 Breast Cancer Treatment Devices Breakdown Data by Application
5.1 Global Breast Cancer Treatment Devices Historic Market Size by Application (2018-2023)
5.2 Global Breast Cancer Treatment Devices Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Breast Cancer Treatment Devices Market Size (2018-2029)
6.2 North America Breast Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Breast Cancer Treatment Devices Market Size by Country (2018-2023)
6.4 North America Breast Cancer Treatment Devices Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Treatment Devices Market Size (2018-2029)
7.2 Europe Breast Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Breast Cancer Treatment Devices Market Size by Country (2018-2023)
7.4 Europe Breast Cancer Treatment Devices Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Treatment Devices Market Size (2018-2029)
8.2 Asia-Pacific Breast Cancer Treatment Devices Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Breast Cancer Treatment Devices Market Size by Region (2018-2023)
8.4 Asia-Pacific Breast Cancer Treatment Devices Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Treatment Devices Market Size (2018-2029)
9.2 Latin America Breast Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Breast Cancer Treatment Devices Market Size by Country (2018-2023)
9.4 Latin America Breast Cancer Treatment Devices Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Treatment Devices Market Size (2018-2029)
10.2 Middle East & Africa Breast Cancer Treatment Devices Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Breast Cancer Treatment Devices Market Size by Country (2018-2023)
10.4 Middle East & Africa Breast Cancer Treatment Devices Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Breast Cancer Treatment Devices Introduction
11.1.4 Abbott Laboratories Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Advanced Radiation Therapy
11.2.1 Advanced Radiation Therapy Company Detail
11.2.2 Advanced Radiation Therapy Business Overview
11.2.3 Advanced Radiation Therapy Breast Cancer Treatment Devices Introduction
11.2.4 Advanced Radiation Therapy Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.2.5 Advanced Radiation Therapy Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Breast Cancer Treatment Devices Introduction
11.3.4 Agilent Technologies Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Becton
11.4.1 Becton Company Detail
11.4.2 Becton Business Overview
11.4.3 Becton Breast Cancer Treatment Devices Introduction
11.4.4 Becton Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.4.5 Becton Recent Development
11.5 Xcision Medical Systems, LLC
11.5.1 Xcision Medical Systems, LLC Company Detail
11.5.2 Xcision Medical Systems, LLC Business Overview
11.5.3 Xcision Medical Systems, LLC Breast Cancer Treatment Devices Introduction
11.5.4 Xcision Medical Systems, LLC Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.5.5 Xcision Medical Systems, LLC Recent Development
11.6 BioGenex Laboratories
11.6.1 BioGenex Laboratories Company Detail
11.6.2 BioGenex Laboratories Business Overview
11.6.3 BioGenex Laboratories Breast Cancer Treatment Devices Introduction
11.6.4 BioGenex Laboratories Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.6.5 BioGenex Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Breast Cancer Treatment Devices Introduction
11.7.4 Danaher Corporation Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 Fujifilm Holdings Corporation
11.8.1 Fujifilm Holdings Corporation Company Detail
11.8.2 Fujifilm Holdings Corporation Business Overview
11.8.3 Fujifilm Holdings Corporation Breast Cancer Treatment Devices Introduction
11.8.4 Fujifilm Holdings Corporation Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.8.5 Fujifilm Holdings Corporation Recent Development
11.9 GE Healthcare
11.9.1 GE Healthcare Company Detail
11.9.2 GE Healthcare Business Overview
11.9.3 GE Healthcare Breast Cancer Treatment Devices Introduction
11.9.4 GE Healthcare Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.9.5 GE Healthcare Recent Development
11.10 General Medical Merate SpA
11.10.1 General Medical Merate SpA Company Detail
11.10.2 General Medical Merate SpA Business Overview
11.10.3 General Medical Merate SpA Breast Cancer Treatment Devices Introduction
11.10.4 General Medical Merate SpA Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.10.5 General Medical Merate SpA Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic Breast Cancer Treatment Devices Introduction
11.11.4 Hologic Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.11.5 Hologic Recent Development
11.12 iCAD Inc.
11.12.1 iCAD Inc. Company Detail
11.12.2 iCAD Inc. Business Overview
11.12.3 iCAD Inc. Breast Cancer Treatment Devices Introduction
11.12.4 iCAD Inc. Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.12.5 iCAD Inc. Recent Development
11.13 IceCure Medical Ltd
11.13.1 IceCure Medical Ltd Company Detail
11.13.2 IceCure Medical Ltd Business Overview
11.13.3 IceCure Medical Ltd Breast Cancer Treatment Devices Introduction
11.13.4 IceCure Medical Ltd Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.13.5 IceCure Medical Ltd Recent Development
11.14 IntraOp Medical Corporation
11.14.1 IntraOp Medical Corporation Company Detail
11.14.2 IntraOp Medical Corporation Business Overview
11.14.3 IntraOp Medical Corporation Breast Cancer Treatment Devices Introduction
11.14.4 IntraOp Medical Corporation Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.14.5 IntraOp Medical Corporation Recent Development
11.15 Myriad Genetics
11.15.1 Myriad Genetics Company Detail
11.15.2 Myriad Genetics Business Overview
11.15.3 Myriad Genetics Breast Cancer Treatment Devices Introduction
11.15.4 Myriad Genetics Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.15.5 Myriad Genetics Recent Development
11.16 Parascript, LLC
11.16.1 Parascript, LLC Company Detail
11.16.2 Parascript, LLC Business Overview
11.16.3 Parascript, LLC Breast Cancer Treatment Devices Introduction
11.16.4 Parascript, LLC Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.16.5 Parascript, LLC Recent Development
11.17 Philips Healthcare
11.17.1 Philips Healthcare Company Detail
11.17.2 Philips Healthcare Business Overview
11.17.3 Philips Healthcare Breast Cancer Treatment Devices Introduction
11.17.4 Philips Healthcare Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.17.5 Philips Healthcare Recent Development
11.18 Planmed Oy
11.18.1 Planmed Oy Company Detail
11.18.2 Planmed Oy Business Overview
11.18.3 Planmed Oy Breast Cancer Treatment Devices Introduction
11.18.4 Planmed Oy Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.18.5 Planmed Oy Recent Development
11.19 Qiagen NV
11.19.1 Qiagen NV Company Detail
11.19.2 Qiagen NV Business Overview
11.19.3 Qiagen NV Breast Cancer Treatment Devices Introduction
11.19.4 Qiagen NV Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.19.5 Qiagen NV Recent Development
11.20 Roche Holding AG
11.20.1 Roche Holding AG Company Detail
11.20.2 Roche Holding AG Business Overview
11.20.3 Roche Holding AG Breast Cancer Treatment Devices Introduction
11.20.4 Roche Holding AG Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.20.5 Roche Holding AG Recent Development
11.21 Sanarus Technologies Inc.
11.21.1 Sanarus Technologies Inc. Company Detail
11.21.2 Sanarus Technologies Inc. Business Overview
11.21.3 Sanarus Technologies Inc. Breast Cancer Treatment Devices Introduction
11.21.4 Sanarus Technologies Inc. Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.21.5 Sanarus Technologies Inc. Recent Development
11.22 Siemens Healthineers AG
11.22.1 Siemens Healthineers AG Company Detail
11.22.2 Siemens Healthineers AG Business Overview
11.22.3 Siemens Healthineers AG Breast Cancer Treatment Devices Introduction
11.22.4 Siemens Healthineers AG Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.22.5 Siemens Healthineers AG Recent Development
11.23 Thermo Fisher Scientific
11.23.1 Thermo Fisher Scientific Company Detail
11.23.2 Thermo Fisher Scientific Business Overview
11.23.3 Thermo Fisher Scientific Breast Cancer Treatment Devices Introduction
11.23.4 Thermo Fisher Scientific Revenue in Breast Cancer Treatment Devices Business (2018-2023)
11.23.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
